BioSpace News Archive

The increasing cases of urea cycle disorder is a key factor augmenting the growth of the global urea cycle disorders treatment market during the forecast period, set between 2020 and 2030.

BioNTech SE, announced that the first patient has been treated in its BNT111 Phase 2 cancer vaccine trial.

Avanos Medical, Inc. announced that Joe Woody, chief executive officer, will present and participate in an analyst-led fireside chat at the Virtual 2021 Raymond James Human Health Innovation Conference Tues., June 22 at approximately 10:40 a.m., ET.

BioXcel Therapeutics, Inc., a clinical-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology, announced that the Company will host a virtual Commercial Day on Friday, June 25, 2021, from 12:00 PM ET – 1:30 PM ET.

Neovasc Inc. announced the publication of an article entitled, “Safety and Efficacy of Coronary Sinus Narrowing in Chronic Refractory Angina: Insights from the RESOURCE Study” in the International Journal of Cardiology.

Predictive Oncology Inc. (NASDAQ: POAI) (“Predictive Oncology” or “the Company”), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced that it has completed the closing of its previously announced registered direct offering of 15,520,911 shares of its common stock and warrants